New small molecule offers hope in combating antibiotic resistance

FHS
May 24, 2024
4:27 pm

Researchers from the University of Oxford have developed a new small molecule that can suppress the evolution of antibiotic resistance in bacteria and make resistant bacteria more susceptible to antibiotics.

Oesophageal cancer: the global clinical trials landscape in 2024 – Pharmaceutical Technology

Illustration showing malignant tumor in the human oesophagus. Credit: Shutterstock Oesophageal cancer is the 11th most diagnosed cancer and the 7th leading cause of cancer

August 28, 2024

FDA puts added emphasis on amyloid in update on Alzheimer’s R&D guidance

The FDA on Monday released newly-revised guidance on early Alzheimer’s disease drug development, including a section that boosts the case for using amyloid reduction as

March 12, 2024

H1 Expands Trial Landscape Platform with UK Diversity Data and AI-Powered Site Rescue

What You Should Know: – H1, a provider of healthcare data and analytics, has announced significant enhancements to its Trial Landscape platform. – These updates

October 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.